Fresenius SE & Co. (OTCMKTS:FSNUY) Hits New 52-Week Low – Should You Sell?

Posted by Doug Wharley on May 15th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as $11.2271 and last traded at $11.27, with a volume of 48031 shares changing hands. The stock had previously closed at $11.71.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on FSNUY. Citigroup reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, April 20th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy”.

View Our Latest Stock Analysis on FSNUY

Fresenius SE & Co. Stock Up 0.2%

The company has a market capitalization of $25.80 billion, a P/E ratio of 15.27 and a beta of 0.68. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.32. The stock has a 50 day moving average price of $12.75 and a 200 day moving average price of $14.02.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The company had revenue of $6.75 billion for the quarter, compared to the consensus estimate of $6.79 billion. Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.29%. Equities research analysts forecast that Fresenius SE & Co. will post 1.05 earnings per share for the current fiscal year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.